876 — Kaisa Health group Share Price
- HK$105.88m
- -HK$50.44m
- HK$185.88m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.22 | ||
Price to Tang. Book | 0.23 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.57 | ||
EV to EBITDA | -1.03 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 1.93% | ||
Return on Equity | 1.53% | ||
Operating Margin | 5.23% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | HK$m | 251.62 | 183.81 | 209.63 | 191.5 | 185.88 | n/a | n/a | -5.14% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Kaisa Health Group Holdings Ltd, formerly Mega Medical Technology Ltd, is an investment holding company principally engaged in the manufacture and sale of dental prosthetics. The Company operates its business through three segments. The Dental Prosthetics Business segment is engaged in the manufacture and sale of dental prosthetics. The Health Care Rehabilitation Business segment provides public health and medical services, including postoperative rehabilitation, sports injury rehabilitation, chronic pain, scoliosis, deformity correction and other rehabilitation services. The Health Care Health Leisure Business segment provides agricultural (cultural) tourism and construction of health care real estate projects.
Directors
- Huagang Zhang CHM (57)
- Hiu Yan Kwok CPR (23)
- Jun Luo CEO (36)
- Tianyu Wu VCH
- Sisi Jiang COO
- Zhigang Xu VPR (48)
- Hoi Wun Hui CTR (44)
- Ying Shing Kwok EDR (56)
- Kwok Leung Yu SEC (44)
- Yonglan Li NID (41)
- Yanwen Liu NID (55)
- Aiping Lyu NID (57)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 23rd, 1997
- Public Since
- April 10th, 1997
- No. of Employees
- 893
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 5,042,139,374
- Address
- 30/F.
- Web
- http://www.kaisahealth.com/
- Phone
- +852 null39690008
- Auditors
- Elite Partners CPA Limited
Upcoming Events for 876
Similar to 876
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:12 UTC, shares in Kaisa Health group are trading at HK$0.02. This share price information is delayed by 15 minutes.
Shares in Kaisa Health group last closed at HK$0.02 and the price had moved by -60.38% over the past 365 days. In terms of relative price strength the Kaisa Health group share price has underperformed the FTSE Developed Asia Pacific Index by -58.64% over the past year.
There is no consensus recommendation for this security.
Kaisa Health group does not currently pay a dividend.
Kaisa Health group does not currently pay a dividend.
Kaisa Health group does not currently pay a dividend.
To buy shares in Kaisa Health group you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.02, shares in Kaisa Health group had a market capitalisation of HK$105.88m.
Here are the trading details for Kaisa Health group:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 876
Based on an overall assessment of its quality, value and momentum Kaisa Health group is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kaisa Health group. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -60.71%.
As of the last closing price of HK$0.02, shares in Kaisa Health group were trading -34.13% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Kaisa Health group PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Kaisa Health group's management team is headed by:
- Huagang Zhang - CHM
- Hiu Yan Kwok - CPR
- Jun Luo - CEO
- Tianyu Wu - VCH
- Sisi Jiang - COO
- Zhigang Xu - VPR
- Hoi Wun Hui - CTR
- Ying Shing Kwok - EDR
- Kwok Leung Yu - SEC
- Yonglan Li - NID
- Yanwen Liu - NID
- Aiping Lyu - NID